Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.60475
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, a...

202.99 -5.76 (-2.76%)

71.98% Gain from 52W Low

894.0K

XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Board Meeting

The board meeting for Ascendis Pharma A/S (ADR) is scheduled for today, for the purpose of 44(th) Annual J.P. Morgan Healthcare Conference See details

Not Eligible

Expensive Valuation

5.5 / 100

Technically Neutral

58.7 / 100

262

1Yr Price target upside is 29%

15 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..